SCHEMBL6523533

SCHEMBL6523533

NC(=O)c1cc(N2CCCC2=O)ccc1Br

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.51
HPGD P15428 6/20 0.50
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50
NPC1 O15118 6/20 0.49
SMN1; SMN2 Q16637 5/20 0.49
RAB9A P51151 4/20 0.49
POLB P06746 2/20 0.49
MAPT P10636 2/20 0.49
RECQL P46063 1/20 0.49
LRRK2 Q5S007 1/20 0.46
MEN1 O00255 3/20 0.45
KMT2A Q03164 3/20 0.45
GAA P10253 1/20 0.45
TSHR P16473 3/20 0.44
DUSP3 P51452 1/20 0.43
PTPN5 P54829 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8140920 0.82 SMN1; SMN2 (0.48) ALDH1A1HPGDCYP1A2CYP3A4CYP2D6
SCHEMBL6523537 0.80 ALDH1A1 (0.50) ALDH1A1HPGDCYP1A2CYP3A4CYP2D6
SCHEMBL5395671 0.79 HPGD (0.49) ALDH1A1HPGDCYP1A2CYP3A4CYP2D6
SCHEMBL5387030 0.79 ALDH1A1 (0.49) ALDH1A1HPGDCYP1A2CYP3A4CYP2D6
SCHEMBL27857205 0.78 LRRK2 (0.41) ALDH1A1HPGDCYP1A2CYP3A4CYP2D6
SCHEMBL26920629 0.77 SLC6A2 (0.50) ALDH1A1HPGDCYP1A2CYP3A4CYP2D6
SCHEMBL5385464 0.77 ALDH1A1 (0.47) ALDH1A1HPGDCYP1A2CYP3A4CYP2D6
SCHEMBL4101204 0.76 ALDH1A1 (0.47) ALDH1A1HPGDCYP1A2CYP3A4CYP2D6
SCHEMBL5830502 0.76 BRD9 (0.51) ALDH1A1HPGDCYP1A2CYP3A4CYP2D6
SCHEMBL17080016 0.76 ALDH1A1 (0.49) ALDH1A1HPGDCYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8435990-B2 Dihydropyrimidone amides as P2X7 modulators ROCHE PALO ALTO LLC (US) 2013-05-07 US disclosed
US-20110028502-A1 DIHYDROPYRIMIDONE AMIDES AS P2X7 MODULATORS BROTHERTON-PLEISS CHRISTINE E 2011-02-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110028502-A1 DIHYDROPYRIMIDONE AMIDES AS P2X7 MODULATORS P2RY1, P2RX7, P2RX3 ALDH1A1 1357/4885HPGD 1322/4885CYP1A2 1996/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.